Concepedia

Publication | Closed Access

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

DOI

730

Citations

24

References

2011

Year

Ludwig Kappos, David Li, Peter A. Calabresi, Paul O’Connor, Amit Bar‐Or, Frederik Barkhof, Ming Yin, David Leppert, Robert Glanzman, Jeroen Tinbergen,
The Lancet

References

YearCitations

Page 1